Cited by 662Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Open access

Adabag, A. Selcuk, Maron, Barry J., Appelbaum, Evan, Harrigan, Caitlin J., Buros, Jacqueline L., Gibson, C. Michael, Lesser, John R., Hanna, Constance A., Udelson, James E., Manning, Warren J., Maron, Martin S.·2008·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2007.11.071

Open this paper in CoChat — free account Open PDF

Abstract

Objectives Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM).Background Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain.Methods We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 +/- 16 yrs; 95% asymptomatic or mildly symptomatic).Results Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007). Patients with DE also had greater numbers of PVCs (202 +/- 655 vs. 116 +/- 435), couplets (1.9 +/- 5 vs. 1.2 +/- 10), and NSVT runs (0.4 +/- 0.8 vs. 0.06 +/- 0.4) than non-DE patients (all p < 0.0001); DE was an independent predictor of NSVT (relative risk 7.3, 95% confidence interval 2.6 to 20.4; p < 0.0001). However, extent (%) of DE was similar in patients with and without PVCs (8.2% vs. 9.1%; p = 0.93), couplets (8.5% vs. 8.4%; p = 0.99), or NSVT (8.3% vs. 8.5%; p = 0.35).Conclusions In this large HCM cohort with no or only mild symptoms, myocardial fibrosis detected by CMR was associated with greater likelihood and increased frequency of ventricular tachyarrhythmias (including NSVT) on ambulatory Holter ECG. Therefore, contrast-enhanced CMR identifies HCM patients with increased susceptibility to ventricular tachyarrhythmias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2007.11.071

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K. R., Chen, E.-L., Simonetti, O. P., Bundy, J. M., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,583
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citation
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Self-citation
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394
Self-citation
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy
Grothues, F., Smith, G. C., Moon, J. C. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02381-0 · Cited by 1,267
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J. C., Smith, G., Burman, E., KHAN, M. G., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,163
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U. P., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citation

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 401–500 of 661

Medical Management of Hypertrophic Cardiomyopathy
Naghi, J. J., & Siegel, R. J. (2010) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0546 · Cited by 7
MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors
Amano, Y., Kitamura, M., Takayama, M., Tachi, M., & Kumita, S. (2012) · International journal of cardiac imaging · doi:10.1007/s10554-012-0034-4 · Cited by 7
Cardiac magnetic resonance imaging: current status and future directions
Cannan, C. R., & Friedrich, M. G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.46 · Cited by 7
The Role of Echocardiography in Hypertrophic Cardiomyopathy
Williams, L. K., Gruner, C., & Rakowski, H. (2015) · Current Cardiology Reports · doi:10.1007/s11886-014-0560-x · Cited by 7
of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society American Association for Thoracic Surgery, American Society of Foundation/American Heart Association Task Force on Practice Guidelines Cardiomyopathy: A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic
Towbin, J. A., Udelson, J. E., Nishimura, R. A., Ommen, S. R., Rakowski, H., Bonow, R. O., Dearani, J. A., Fifer, M. A., Gersh, B. J., & Maron, B. J. (2011) · Cited by 7
Self-citation
Characteristics of Disturbances of Heart Rhythm and Conduction Among Patients Attending Consultation of a Cardiologist at Ambulatory Stage
Getman, S. I. (2018) · Kardiologiia · doi:10.18087/cardio.2018.6.10130 · Cited by 7
For Whom the Bell Tolls
Tonchev, I., Luria, D. M., Orenstein, D., Lotan, C., & Biton, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1191-z · Cited by 8
The Role of MRI in Prognostic Stratification of Cardiomyopathies
Grigoratos, C., Todiere, G., Barison, A., & Aquaro, G. D. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01311-3 · Cited by 7
Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus
Raza, M., Chalfoun, N. T., Abdallah, W. M., Hashmi, H., & McNamara, R. F. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.9 · Cited by 7
Nonsustained Ventricular Tachycardia
Katritsis, D. G., Zaręba, W., & Camm, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00045-4 · Cited by 7
Risk stratification for sudden cardiac death after septal myectomy
Rothman, R. D., Safiia, M. A., Lowry, P. A., Mela, T., Abbara, S., O’Callaghan, C., Mark, E. J., Vlahakes, G. J., & Fifer, M. A. (2011) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2010.12.002 · Cited by 7
Inherited Cardiomyopathies
O’Hanlon, R., & Mohiaddin, R. H. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4267-6_13 · Cited by 7
The missing spade: apical hypertrophic cardiomyopathy investigation
Alpendurada, F., & Prasad, S. K. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9335-z · Cited by 7
Evaluation of sudden cardiac death in hypertrophic cardiomyopathy
Yoon, S. G., & Hong, G. (2025) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-025-00054-5 · Cited by 7
Proteomics of pediatric heart failure: from traditional biomarkers to new discovery strategies
Xu, M., Ramirez‐Correa, G. A., & Murphy, A. M. (2015) · Cardiology in the Young · doi:10.1017/s1047951115000839 · Cited by 6
Hypertrophic Cardiomyopathy
Maron, B. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00069-x · Cited by 6
Self-citation
Magnetic Resonance Imaging of the Myocardium, Coronary Arteries, and Anomalous Origin of Coronary Arteries
Cheong, B., & Angelini, P. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_13 · Cited by 6
Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?
van der Wall, E. E., Siebelink, H.-M., & Bax, J. J. (2010) · Netherlands Heart Journal · doi:10.1007/bf03091748 · Cited by 6
Actualización en técnicas de imagen cardiaca: ecocardiografía, resonancia magnética en cardiología y tomografía computarizada con multidetectores
del Castillo, S. V., Aguilar, R., & Bardera, J. C. P. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70047-8 · Cited by 6
Left Ventricular Hypertrophy and Excess Cardiovascular Mortality
Chuang, M. L., & Manning, W. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.025 · Cited by 6
Self-citation
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques
Kasiakogias, A., Kaskoutis, C., Antoniou, C. K., Georgopoulos, S., Tsiachris, D., Αρσένος, Π., Kouroutzoglou, A., Klettas, D., Vlachopoulos, C. V., Tsioufis, K. P., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12030101 · Cited by 5
Hypertrophic Cardiomyopathy–Advances in Imaging and Diagnostic Strategies
Fries, R. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.05.010 · Cited by 5
Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death
Sugiura, Y., Morimoto, R., Aoki, S., Yamaguchi, S., Haga, T., Kuwayama, T., Yokoi, T., Hiraiwa, H., Kondo, T., Watanabe, N., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01440-y · Cited by 5
Expressão fenotípica da miocardiopatia hipertrófica e realce tardio na ressonância magnética cardíaca
Caetano, F., Botelho, A., Trigo, J., Silva, J., Almeida, I. G., Venâncio, M., Pais, J., Sanches, C., & Marques, A. L. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.10.005 · Cited by 5
Implantable Defibrillators in Long QT Syndrome, Brugada Syndrome, Hypertrophic Cardiomyopathy, and Arrhythmogenic Right Ventricular Cardiomyopathy
Dohadwala, M., & Link, M. S. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.11.003 · Cited by 5
Surgery of Hypertrophic Obstructive Cardiomyopathy in Patients With Severe Hypertrophy, Myocardial Fibrosis, and Ventricular Tachycardia
Borisov, K. V. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.02.017 · Cited by 5
Atrial Fibrillation in Hypertrophic Cardiomyopathy
Игнатенко, Г. А., Тарадин, Г. Г., Ватутин, Н. Т., Kaluga, A. A., & Kostyamin, Y. D. (2021) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2021-11-3-173-185 · Cited by 5
Myocarditis, myocardial fibrosis and eligibility for competitive sports
Preßler, A., Schmid, A., Freiberger, V., Scherr, J., Uder, M., & Halle, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.054 · Cited by 5
Role of Cardiac Magnetic Resonance Imaging in the Management and Treatment of Ventricular Tachycardia in Patients With Structural Heart Disease
Mehrotra, A. K., & Callans, D. J. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0606 · Cited by 5
Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Dimitrow, P. P., Klimeczek, P., Vliegenthart, R., Pasowicz, M., Miszalski−Jamka, T., Oudkerk, M., Podolec, P. S., Dubiel, J. S., & Tracz, W. (2009) · PubMed · Cited by 5
Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage
Pozo, E., Viliani, D., Aguirre, N., Agudo-Quílez, P., Olivera, M. J., Caballero, P., Jiménez‐Borreguero, L. J., & Alfonso, F. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0954-5 · Cited by 5
State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies
Laczay, B., Patel, D. R., Grimm, R. A., & Xu, B. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-724 · Cited by 4
Ressonância Magnética Cardíaca como Ferramenta Diagnóstica Etiológica em Pacientes Recuperados de Morte Súbita Cardíaca ou Arritmias Ventriculares Instáveis
Marçal, P. C., Braggion-Santos, M. F., Wada, D. T., Santos, M., Moreira, H., Volpe, G., & Schmidt, A. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220411 · Cited by 4
Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
Burnasheva, G. A., Myasnikov, R. P., Kulikova, O. V., Kudryavtseva, M. M., Mershina, E. A., & Drapkina, O. M. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3839 · Cited by 4
Risk Stratification in Hypertrophic Cardiomyopathy: Is Two-Dimensional Echocardiographic Strain Ready for Prime Time?
Maron, M. S., & Pandian, N. G. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.04.002 · Cited by 4
Self-citation
Cardiac Magnetic Resonance Imaging Identification of Myocardial Fibrosis
Kramer, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.063 · Cited by 4
Merging strain-echo measurements with late gadolinium enhancement at cardiac MRI: An upcoming chance for advanced functional assessment of fibrosis in hypertrophic cardiomyopathy?
GREGORIO, C. D., & Bella, G. D. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.245 · Cited by 4
CCTA Cardiac Electrophysiology Applications: Substrate Identification, Virtual Procedural Planning, and Procedural Facilitation
Shinbane, J. S., Saxon, L. A., Doshi, R. N., Chang, P. M., & Budoff, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-28219-0_24 · Cited by 4
Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
Li, L., Ban, C., Ruan, H., Zhang, M., Wang, Z., Ma, M., Zheng, Y., & He, S. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03562-8 · Cited by 4
How to diagnose the cause of sudden cardiac arrest.
Lim, H. S., Subbiah, R. N., Leong‐Sit, P., Gula, L. J., Skanes, A. C., Yee, R., Klein, G. J., & Krahn, A. D. (2011) · PubMed · Cited by 4
Thirty Controversies and Considerations in Hypertrophic Cardiomyopathy
Masri, A., Nazer, B., Al‐Rashdan, L., Mannello, M., Fischer, K. L., Akhavein, R., Divanji, P., Song, H. K., & Heitner, S. B. (2020) · Structural Heart · doi:10.1080/24748706.2020.1844926 · Cited by 4
Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
Uretsky, S. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.04.005 · Cited by 4
Evolving Anatomic, Functional, and Molecular Imaging in the Early Detection and Prognosis of Hypertrophic Cardiomyopathy
Fuster, V., van der Zee, S. A., & Miller, M. A. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9133-6 · Cited by 4
Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy
Amado, L. C., & Lima, J. A. C. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283383d1d · Cited by 4
Myocardial siderosis due to hemochromatosis in an individual with hypertrophic cardiomyopathy
Hildebrand, A. M., Bhagirath, K. M., Ariyarajah, V., Walker, J. R., Houston, D. S., Zieroth, S. R., Tam, J. W., Kirkpatrick, I. D. C., & Jassal, D. S. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70538-0 · Cited by 4
Device therapy in hypertrophic cardiomyopathy
Beadle, R. M., & Williams, L. K. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.156 · Cited by 4
Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes
McDermott, S. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i4.103 · Cited by 4
Late gadolinium enhancement in cardiomyopathy
Alpendurada, F., & Pennell, D. J. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9316-2 · Cited by 4
Magnetic resonance imaging in the evaluation of congestive cardiac failure
Rajiah, P. S. (2012) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.4103/0971-3026.107177 · Cited by 3
Efficiency and Governance of Power Corporations: A China and Taiwan Analysis
Chang, M. (2014) · Polish Journal of Environmental Studies · Cited by 3
Magnetic Resonance Imaging for Hypertrophic Cardiomyopathy Update
Chan, A., Somarouthu, B., & Ghoshhajra, B. B. (2014) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000010 · Cited by 3
Arrhythmia Evaluation and Management
Jacobson, J. T. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.005 · Cited by 3
Case report: Double-chambered right ventricle diagnosed in a middle-aged female with hypertrophic cardiomyopathy and atrial flutter: A rare case
Ge, J., Hu, T., Liu, Y., Wang, Q., Fan, G., Liu, C., Zhang, J., Chen, S., Maduray, K., Zhang, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.937758 · Cited by 3
Surgery for ventricular tachycardia originating from the left ventricular summit
Nitta, T., Sakamoto, S., Murata, H., Suzuki, K., Yamada, N., Iwasaki, Y., & Ishii, Y. (2023) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad323 · Cited by 3
Cardiovascular magnetic resonance in the evaluation of heart failure
D’Andrea, A., Fontana, M., Cocchia, R., Scarafile, R., Calabrò, R., & Moon, J. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834e4ad4 · Cited by 3
Heart Muscle Diseases
Bogaert, J. G., & Taylor, A. M. (2011) · Medical radiology · doi:10.1007/174_2011_358 · Cited by 3
Ventricular arrhythmias in hypertrophic cardiomyopathy--can we ever predict them?
Namboodiri, N., & Francis, J. (2010) · PubMed Central · Cited by 3
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
Cheitlin, M. D. (2011) · Yearbook of Cardiology · doi:10.1016/j.ycar.2011.01.015 · Cited by 3
Applications of Advanced Imaging in Cardiac Electrophysiology
Yadava, M., & Shapiro, M. D. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0491-5 · Cited by 3
Three Achilles’ heels of alcohol septal ablation
Kashtanov, M. G., Chernyshev, S., Kardapoltsev, L. V., Berdnikov, S., & Idov, E. M. (2017) · Patologiya krovoobrashcheniya i kardiokhirurgiya · doi:10.21688/1681-3472-2017-3-12-22 · Cited by 3
Mapping and Ablation of Ventricular Arrhythmias in Cardiomyopathies
Hsia, H. H., & Xiong, N. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.08.005 · Cited by 3
Hypertrophic Cardiomyopathy
Sorajja, P., & Ommen, S. R. (2010) · Springer eBooks · doi:10.1007/978-0-387-92775-6_13 · Cited by 3
Hypertrophic cardiomyopathy
Chan, C., & Maron, M. S. (2018) · doi:10.1093/med/9780198779735.003.0022 · Cited by 3
Self-citation
Hypertrophic Cardiomyopathy
Chan, R. H. M., & Maron, M. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8875-0_16 · Cited by 3
Self-citation
Hypertrophic Cardiomyopathy
Slyngstad, T., & Cove, C. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-89725-7_14 · Cited by 3
Hypertrophic Cardiomyopathy
Colan, S. D., & Margossian, R. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00019-3 · Cited by 3
Likelihood of Ventricular Arrhythmias Due to Myocardial Fibrosis in Hypertrophic Cardiomyopathy as Detected by Cardiac Magnetic Resonance Imaging
Dhoble, A., Punnam, S. R., & Abela, G. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.050 · Cited by 3
Arrhythmias in Feline Cardiomyopathies
Anderson, E. L. (2018) · doi:10.1002/9781119254355.ch21 · Cited by 3
Outcomes of Transcatheter Edge-to-Edge Mitral Valve Repair in Hypertrophic Cardiomyopathy: A Patient-Level Meta-Analysis
Mascarenhas, L., Yang, G., Sharma, A. N., Bertog, S. C., Hubers, S. A., & Adabağ, S. (2025) · Structural Heart · doi:10.1016/j.shj.2025.100664 · Cited by 2
Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis
Siddiqi, A. K., Maniya, M. T., Bilen, O., Abdou, M. A. H., Cecco, C. N. D., & Naeem, M. (2025) · European Radiology · doi:10.1007/s00330-025-11961-y · Cited by 2
Treatment of ventricular tachycardia: consider ablation sooner
Bloom, H. L. (2009) · F1000 Medicine Reports · doi:10.3410/m1-71 · Cited by 2
Echocardiography in 2009: The Future of Clinical Diagnosis
Nihoyannopoulos, P. (2009) · Future Cardiology · doi:10.2217/fca.09.60 · Cited by 2
Novedades en cardiología clínica: patología de la aorta, miocardiopatía hipertrófica y profilaxis de la endocarditis infecciosa
Borràs, X., Gallego, P., & Monserrat, L. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70039-9 · Cited by 2
Hypertrophic Cardiomyopathy: A New Mutation Illustrates the Need for Family-Centered Care
Lee, D. D., Veith, R. L., Dimmock, D., & Samyn, M. M. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-1002-7 · Cited by 2
Valor diagnóstico de la resonancia magnética cardiaca en la insuficiencia cardiaca: estado actual
Chaparro‐Muñoz, M., & Prasad, S. K. (2011) · Cardiocore · doi:10.1016/j.carcor.2011.01.004 · Cited by 2
MRI with late gadolinium enhancement as a predictor of ventricular arrhythmias
Wu, K. C. (2009) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-009-0015-8 · Cited by 2
Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy
Naeger, D. M., Higgins, C. B., Marco, T. D., Muzzarelli, S., & Ordovas, K. G. (2015) · Clinical Imaging · doi:10.1016/j.clinimag.2015.01.001 · Cited by 2
The Year in Imaging Related to Electrophysiology
Tops, L. F., & Bax, J. J. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.12.023 · Cited by 2
Cardiac Imaging in RASopathies/Mitogen Activated Protein Kinase Syndromes
Gravino, R., & Pacileo, G. (2014) · Cardiogenetics · doi:10.4081/cardiogenetics.2014.2198 · Cited by 2
Assessing the Athlete’s Heart
Weiner, R. B., & Baggish, A. L. (2012) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-012-9165-1 · Cited by 2
Cardiac Magnetic Resonance Imaging as a Prognostic Tool in Patients with Nonischemic Cardiomyopathy
Partington, S. L., Seabra, L. F., & Kwong, R. Y. K. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.343 · Cited by 2
Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
Rodríguez-Granillo, G. A., Deviggiano, A., Capuñay, C., Zan, M. C. D., & Carrascosa, P. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160087 · Cited by 2
Assessment of Myocardial Fibrosis in Hypertrophic Cardiomyopathy by Cardiac Magnetic Resonance: Modalities and Clinical Applications
Contaldi, C. (2016) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v8i0.253 · Cited by 2
Ventricular arrhythmias and sudden death in hypertrophic cardiomyopathy
Durdil, V. (2010) · Cor et Vasa · doi:10.33678/cor.2010.118 · Cited by 2
Cardiovascular Magnetic Resonance Imaging Tissue Characterization in Non-ischemic Cardiomyopathies
Rodriguez-Ortiz, J., Abuzaid, A., Agbor-Etang, B. B., & Ordovas, K. G. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00813-1 · Cited by 2
The Year in Cardiac Imaging
Gibbons, R. J., Araoz, P. A., & Williamson, E. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.036 · Cited by 2
Cardiovascular Magnetic Resonance Imaging
Kwong, R. Y. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00018-4 · Cited by 2
Delayed-enhancement cardiac MRI in the evaluation of cardiomyopathies
Boonyasiranant, T., & Flamm, S. D. (2010) · Imaging in Medicine · doi:10.2217/iim.10.18 · Cited by 2
Ventricular Arrhythmias and Heart Failure
Ellis, E. R., & Josephson, M. E. (2017) · Springer eBooks · doi:10.1007/978-1-4471-4219-5_15 · Cited by 2
Sudden Cardiac Death Risk Stratification and the Role of the Implantable Cardiac Defibrillator
Iwai, S. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.011 · Cited by 2
Delayed Hyperenhancement Magnetic Resonance Imaging for Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy
Efthimiadis, G. K., & Pagourelias, E. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.068 · Cited by 2
Concomitant Septal Myectomy with Aortic Valve Replacement for Severe Aortic Stenosis with Left Ventricular Outflow Tract Obstruction
Umetsu, A., Matsushita, S., Kinoshita, T., & Tabata, M. (2023) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.jmj22-0036-oa · Cited by 1
Endothelin-1 in the failing Fontan: pathobiology, precision therapeutics, and future trial design
Maiza, I. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1718057 · Cited by 1
Familial Hypertrophic Cardiomyopathy-Related Troponin Mutations and Sudden Cardiac Death
Dewar, L. J., Liang, B., Li, Y., Sanatani, S., & Glen, F. (2012) · InTech eBooks · doi:10.5772/28144 · Cited by 1
Practical applications of cardiovascular magnetic resonance
Alpendurada, F., Wong, J. L., & Pennell, D. J. (2009) · Heart Asia · doi:10.1136/ha.2009.000323 · Cited by 1
Advances of Cardiovascular MRI in Hypertrophic Cardiomyopathy
Kumar, P., Blackshear, J. L., Ibrahim, E. H., Mergo, P. J., Parikh, P. P., Batton, K. A., & Shapiro, B. P. (2013) · Future Cardiology · doi:10.2217/fca.13.58 · Cited by 1
Highlights of the Year in JACC 2008
DeMaria, A. N., Ben‐Yehuda, O., Bax, J. J., Feld, G. K., Greenberg, B., Lew, W. Y. W., Lima, J. A. C., Maisel, A. S., Narayan, S. M., Sahn, D. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.005 · Cited by 1
Sudden Cardiac Risk Assessment
Danik, S. B., Singh, J. P., & Singh, J. P. (2011) · Springer eBooks · doi:10.1007/978-1-84882-486-7_18 · Cited by 1
T1 Mapping for the Study of Cardiac Hypertrophy
Doltra, A., Nasser, S. B., Messroghli, D., Gebker, R., Schnackenburg, B., Pieske, B. M., & Kelle, S. (2015) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-015-9362-9 · Cited by 1
Contemporary Reviews in Cardiovascular Medicine Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Cited by 1
Self-citation

Authors: Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., & Maron, M. S.
Affiliations: Minneapolis Heart Institute Foundation (US)
Beth Israel Deaconess Medical Center (US)
Harvard University (US)
Tufts Medical Center (US)
ORCID: Maron, Barry J.
Buros, Jacqueline L.
Gibson, C. Michael
Lesser, John R.
Udelson, James E.
Manning, Warren J.
Maron, Martin S.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2008-04
Volume: 51
Issue: 14
Pages: 1369-1374
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2007.11.071
OpenAlex: W2076526672
Cited by: 662
References: 43
Citations by year: 2026: 10 · 2025: 12 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 24 · 2020: 24 · 2019: 28 · 2018: 32 · 2017: 29 · 2016: 39 · 2015: 42 · 2014: 64 · 2013: 48 · 2012: 60
FWCI: 50.64
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1932 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Clinical Science Research and Development
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, myocardial fibrosis, late gadolinium enhancement, cardiovascular magnetic resonance, ventricular arrhythmias, non-sustained ventricular tachycardia, premature ventricular contractions, arrhythmogenic substrate, Holter monitoring, asymptomatic patients, arrhythmic risk stratification, contrast-enhanced MRI, cardiac resynchronization therapy, implantable cardioverter-defibrillator
MeSH terms: Adolescent, Adult, Aged, Cardiomyopathy, Hypertrophic, Female, Fibrosis, Health Status Indicators, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Tachycardia, Time Factors, Prevalence, Risk Assessment, Blood Pressure Monitoring, Ambulatory, Ventricular Premature Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks